The human immunodeficiency virus type 1 (HIV-1) Nef protein is required for efficient virus replication in vivo and displays a number of distinct and apparently unrelated biological activities in vitro. Of these, one of the most readily demonstrated is the efficient internalization and degradation of cellsurface CD4, the receptor for the HIV-1 envelope protein. The biological purpose of this internalization has, however, remained unclear.
Background
Infection of cells by human immunodeficiency virus type 1 (HIV-1) requires an initial interaction between the viral envelope protein (Env) and the cell-surface CD4 glyco-protein [1] [2] [3] [4] [5] . Remarkably, no less than three out of a total of nine gene products encoded by HIV-1 can specifically inhibit the cell-surface expression of CD4 and, hence, render cells resistant to infection (reviewed in [6] ). The first of these is Nef, a viral early gene product that induces the internalization and degradation of cell-surface CD4 molecules [7] [8] [9] [10] [11] . In contrast, the viral Env protein, which is a late gene product, forms a complex with CD4 in the endoplasmic reticulum (ER), resulting in the retention of both newly synthesized CD4 and Env in the ER [12] . Finally, Vpu, another late viral gene product, binds the intracytoplasmic domain of CD4 molecules in the ER and then targets them for degradation by the proteasome [13, 14] . Vpu, therefore, not only prevents newly synthesized CD4 from reaching the cell membrane but also significantly increases cell-surface expression of Env. In contrast, Nef does not affect CD4 production but induces the rapid removal of pre-existing CD4 molecules from the surface of the cell shortly after HIV-1 infection [7] [8] [9] .
Although the interaction of Env with CD4 in the ER could be viewed as inadvertent, and the role of Vpu as being primarily to facilitate the efficient transport of Env to the cell surface in CD4-expressing cells, it appears that CD4 downregulation by Nef is designed to selectively remove this essential HIV-1 receptor from the surface of infected cells. Because this action renders cells refractory to HIV-1 infection [11] , Nef might be acting to prevent the cytopathic effects induced by retroviral superinfection. Alternatively, the removal of cell-surface CD4 might facilitate the release of progeny HIV-1 virions that might otherwise be trapped by CD4 molecules present in the plasma membrane of infected cells. Despite the attractiveness of this latter hypothesis, no evidence has yet been reported to support it. Downregulation of CD4 by Nef is believed to involve the direct and specific interaction of Nef with, on the one hand, a dileucine motif present in the CD4 intracytoplasmic domain [7, 15, 16] and, on the other, one or more adaptor protein (AP) complexes [17] [18] [19] . These AP complexes are then believed to target CD4 for internalization by way of clathrin-coated pits and finally for degradation in lysosomes. Nef also induces the internalization and degradation of class I MHC molecules, the removal of which might confer partial resistance to lysis of the infected cell by HIV-1-specific cytotoxic T lymphocytes in vivo [17, 18, 20] . Class I MHC internalization is also thought to involve binding of Nef to the class I MHC intracytoplasmic domain, albeit to a different target sequence from that in CD4, and to AP complexes [17, 18] . In addition to CD4 and class I MHC downregulation, Nef has also been reported to cause a modest increase in the infectivity of HIV-1 virions produced from nef-expressing cells [21] [22] [23] [24] [25] . This increased infectivity can vary from imperceptible to more than 10-fold, depending on the experimental system used, but is most obvious when quiescent T cells are infected before activation [21, 22] . These latter two activities of Nef are, at least in part, functionally distinct from CD4 downregulation, in that mutation of a proline-rich SH3-binding motif in Nef has been reported to inhibit both class I MHC downregulation and Nef-enhanced virion infectivity, yet does not reduce the efficiency of CD4 downregulation [15, 17, 26] . Finally, Nef expression has also been reported to affect the activation state of cells [27, 28] , although the significance of this finding, and whether it represents yet a fourth independent phenotype of Nef, is still unclear.
Despite the varied activities ascribed to the nef gene product, Nef has only a modest positive effect on HIV-1 replication in culture in most experimental systems [21, 29, 30] . In vivo evidence from monkeys infected with simian immunodeficiency virus (SIV) [29] , as well as from HIV-1-infected immunodeficient mice implanted with human tissues [31] , clearly shows that Nef is important for efficient viral replication and, hence, for pathogenesis. Even in vivo, however, Nef is not absolutely essential. For example, in neonatal monkeys, SIV carrying deletions in nef can occasionally replicate to appreciable titers and cause disease [32] . The fact that the nef gene product as a whole is not critical for HIV-1 replication implies that the individual contributions of the three or four distinct Nef activities to the overall rate of viral replication might well be modest.
The hypothesis that cell-surface CD4 can inhibit the release of progeny HIV-1 virions from infected cells predicts that the level of inhibition should be proportional to the amount of cell-surface CD4. It has, in fact, previously been shown that cells expressing very high levels of CD4 are unable to support a spreading HIV-1 infection in culture [33] . Conversely, the increase in the release of progeny HIV-1 virions that results from the Nef-mediated downregulation of cell-surface CD4, if it occurs, should become more apparent with higher initial levels of CD4 expression. We therefore examined the effect of Nef on the release of HIV-1 virions from 293T cells, which express a level of CD4 ~20-fold higher than the average level on transformed T cells. We observed that Nef could indeed dramatically enhance the release of HIV-1 virions from these CD4 + cells, but not from 293T cells expressing comparable levels of CD8. This effect was abrogated when a CD4 mutant refractory to Nef downregulation was used, or when the HIV-1 Env protein was replaced with an amphotropic murine retroviral Env protein. These data, therefore, show that cell-surface CD4 can indeed inhibit the release of progeny HIV-1 virions and they provide evidence for the hypothesis that CD4 downregulation by Nef can effectively counter this inhibition.
Results
To test the hypothesis that cell-surface CD4 can specifically inhibit the release of progeny HIV-1 virions by forming complexes with the viral Env protein on the virion surface, and that Nef can alleviate this inhibition by inducing the internalization and degradation of cell-surface CD4, we followed the experimental protocol diagrammed in Figure 1 . On day 1, 293T cells were transfected with an expression vector encoding wild-type or mutant (Nef-nonresponsive) CD4, with CD4 plus Lck, with CD8, with CD8 plus Lck or with the blank vector. At ~70 hours after transfection, the cells were harvested and stained with an anti-CD4 monoclonal antibody, an anti-CD8 monoclonal antibody or, in the case of control transfected cells, mock stained. The cells were then subjected to fluorescenceactivated cell sorting (FACS) and the most highly expressing ~15% cells harvested. The transfection efficiency was 50%, in that 53 ± 4% of cells were gated as CD4 + , and 49 ± 4% gated as CD8 + , averaged over four experiments. Control transfected cells were also passed through the FACScan but were not sorted. The relative levels of expression of CD4 on the harvested population of transfected 293T cells were compared with the levels seen on four representative human T-cell lines (SupT1, H9, CEM-SS and HUT78) analyzed in parallel. Results showed that the cell-surface level of CD4 on these 293T cells varied between ~12-fold higher than the highest CD4 level seen (on SupT1) and ~35-fold higher than the lowest level seen (on CEM-SS; data not shown). A representative FACS analysis comparing the level of anti-CD4 monoclonal antibody staining observed with mock-transfected 293T cells, After harvesting, the different pools of 293T cells were each plated onto 35-mm dishes, at ~3 × 10 5 cells per plate, and allowed to recover for ~24 hours. At this point, cells were transfected with the pNL-Luc + E -R -HIV-1 proviral expression plasmid [34] together with pCR3.1-based expression plasmids encoding a CCR-5-tropic HIV-1 Env protein, or a murine leukemia virus (MLV)-derived amphotropic Env protein, and either wild-type or mutant forms of HIV-1 Nef or SIV mac239 Nef (Nef-S). The Nef expression plasmids were substituted with the blank pCR3.1 plasmid where appropriate. The HIV-1 provirus present in the pNL-Luc + E -R -plasmid lacks a functional env gene and bears the luciferase indicator gene in place of nef [34] . When pseudotyped by a functional Env protein expressed in trans, the released NL-Luc + E -Rvirions are able to undergo one round of infection and then express readily quantifiable levels of luciferase in the infected cells.
At ~63 hours after the second transfection, supernatant media were harvested and analyzed for expression of the internal structural viral protein p24 Gag by ELISA and for infectious virus. For this purpose, 1 ml supernatant media was overlaid onto 293T cells that had been transfected with plasmids expressing CD4 and the CCR-5 co-receptor as previously described [35] . Luciferase levels were quantified at 48 hours after infection and represent an accurate measure of the level of infectious virus in the supernatant media.
We and others have previously shown that HIV-1 Nef can greatly reduce the level of cell-surface CD4 when these proteins are co-expressed in transfected 293T cells [7, 11, 15] . To confirm this earlier result, and to address whether expression of HIV-1 Env, or expression of the HIV-1 Vpu protein encoded by the NL-Luc + E -Rprovirus, would exert a significant effect on the level of cell-surface CD4 during the course of this experimental procedure, we performed a FACS analysis on the re-transfected CD4 + 293T cells on day 7, that is one day before virus harvest ( Figure 1 ). The anti-CD4 monoclonal antibody used, termed L120, was chosen because it recognizes a CD4 epitope that is not occluded by the HIV-1 Env protein [36] . As shown in Figure 2b , CD4 + cells transfected with NL-Luc + E -R -and the Env expression plasmid in fact showed only a very modest (~15%) reduction in the level of cell-surface CD4 at this time point. In contrast, the level of CD4 on the surface of cells transfected with the Nef expression plasmid was reduced bỹ 90%, and this reduction was not further enhanced by coexpression of Env. Therefore, at this point in the experiment, pre-existing cell-surface CD4 has been effectively downregulated by Nef, whereas Env and Vpu, which act only on newly synthesized CD4, have yet to exert a marked effect. Relative cell number
Inhibition of virion release by cell-surface CD4 is relieved by Nef
To examine the effect of Nef on HIV-1 virion release, we transfected control 293T cells, or cells expressing CD4 or CD8 in the presence or absence of the tyrosine kinase Lck, with the NL-Luc + E -R -provirus and an HIV-1-derived env expression plasmid in the presence or absence of an HIV-1 nef expression plasmid. CD8, which neither binds the HIV-1 Env protein nor is affected by Nef, served as a negative control. Lck, which interacts with both CD4 and CD8, was included to see if it would exert any effect in this assay. Western analysis confirmed that Lck was indeed expressed by the transfected 293T cells (data not shown).
As shown in Figure 3a , co-expression of both Env and Nef, in the absence of any CD4, resulted in an approximatley twofold increase in the level of supernatant p24 Gag when compared with the level seen with NL-Luc + E -R -and Env (Env only). In contrast, co-expression of Env with CD4, or with CD4 plus Lck, resulted in an approximately fivefold drop in the level of released p24 compared with the control, Env-only cells or with cells co-transfected with CD8 ± Lck (Figure 3a) . Remarkably, the additional expression of Nef resulted in a complete reversal of this CD4-induced inhibition and fully restored p24 Gag production to the level seen in the absence of CD4 expression. In contrast, Nef had little or no effect on supernatant p24 Gag levels when coexpressed with CD8. Lck appeared to have little or no effect on the level of HIV-1 production when expressed with either CD4 or CD8 (Figure 3a) .
Because Nef has been proposed to enhance the infectivity of HIV-1 virions produced in its presence [21] [22] [23] [24] [25] , including that of virions produced from transfected 293T cells [24] , we wished to contrast the level of infectious virions released in this experiment with the level of p24 Gag production, which measures the total level of released infectious and noninfectious virion capsids. In fact, we observed very little difference between the p24 data, presented in Figure 3a , and the infectious virus data, presented in Figure 3b . Specifically, CD4 ± Lck was again found to inhibit the release of infectious HIV-1 strongly, and this inhibition was again effectively rescued by coexpression of nef. In contrast, Nef had no significant effect on the level of infectious virus produced from CD8-expressing cells. It is possible to derive a coefficient that measures the relative infectivity of the HIV-1 virions released in the presence or absence of Nef by dividing the relative level of infectious virus present per milliliter of supernatant (Figure 3b ) by the relative level of p24 Gag protein per milliliter (Figure 3a) . These numbers, which are given in parentheses in Figure 3b , show that Nef had little or no effect on HIV-1 virion infectivity. Instead, the major effect of Nef was to rescue the release of infectious virus from CD4-expressing cells. In subsequent experiments, we have, therefore, presented only data quantifying the level of release of infectious HIV-1 virions.
Effect of CD4 and Nef on cell-associated virus
The data in Figure 3 show that cell-surface CD4 inhibits the release of HIV-1 virions from transfected 293T cells 616 Current Biology, Vol 9 No 12
Figure 3
Inhibition of virion production by cell-surface CD4 is reversed by HIV-1 Nef. Control 293T cells, as well as 293T cells expressing CD4 or CD8 plus or minus Lck, were transfected with the pNL-Luc + E -R -HIV-1 proviral expression plasmid, and a plasmid expressing an R5 tropic Env protein, in the presence or absence of an HIV-1 Nef expression plasmid. Levels of (a) supernatant p24 Gag protein or (b) infectious HIV-1 were analyzed ~63 h later and are given relative to the level observed in the CD4 -/CD8 -293T cell culture transfected with pNL-Luc + E -R -plus the Env expression plasmid (Env only), which was arbitrarily set at 100%. The data represent the average of three experiments plus or minus the standard deviation. (a) Released p24 levels were determined by ELISA. For the 'Env only' sample, these averaged ~25 ng/ml over three experiments. (b) Infectious virus levels were determined by overlaying 1 ml filtered supernatant media onto 293T cells that express CD4 and CCR-5. After incubation for 2 days, the cells were harvested and lysed and the level of luciferase expression determined. Because the luciferase gene is expressed as part of the defective Luc + E -R -HIV-1 genome, this yields an accurate measure of the level of infectious virus [34, 35] . Numbers in brackets at the end of each bar give the relative infectivity of the virions present in each sample and were derived by dividing the level of infectious virus (b) by the level of released virus (a). and that this inhibition is reversed by expression of HIV-1 Nef. These data are consistent with the hypothesis that CD4 and Nef affect only virus release, and not virus production, but it is also possible that CD4 and Nef have no direct effect on the efficiency of virion release but are instead simply acting to respectively inhibit or boost the synthesis of viral proteins. If the latter case is true, then CD4 expression should also reduce the level of cell-associated Gag protein whereas Nef should enhance it. In contrast, if the level of virus production is constant, and CD4 and Nef are acting at the level of virus release, then cellassociated p24 Gag should increase in the presence of CD4 and decrease in the presence of Nef. As shown in the western analysis in Figure 4 , expression of CD4 in fact increases the level of cell-associated p24 Gag in the transfected 293T cells by twofold to threefold (compare lanes 2 and 3), whereas the co-expression of CD4 with Nef reduces cell-associated p24 levels by approximately sixfold, to a level slightly below that seen in the control CD4 -lane. These data therefore strongly support the hypothesis that Nef is indeed acting to reverse the retention of budding virions caused by cell-surface CD4.
We asked next whether this activity was unique to HIV-1 Nef or whether other Nef proteins would also be active. As shown in Figure 5 , the Nef protein encoded by SIV mac239 Nef, which can also downregulate the cellsurface expression of human CD4 when expressed in 293T cells [15] , could also reverse the inhibition in HIV-1 virus release induced by CD4 expression. Interestingly, SIV Nef did not, however, give rise to the modest (around twofold) CD4-independent increase in infectious HIV-1 virus release seen with HIV-1 Nef (Figure 3 ).
Downregulation of cell-surface CD4 is critical for the effect of Nef on virion release
If Nef is indeed acting to prevent an inhibitory effect of cell-surface CD4 on virion release, then the ability of Nef to induce CD4 internalization should be essential for this activity. To test this hypothesis, we expressed a previously described mutant form of CD4 (LS414/415AA) [15] which is totally refractory to Nef-induced internalization but is expressed at similar levels to wild-type CD4 on the surface of transfected cells. This CD4 mutant (mCD4) was comparable with wild-type in its ability to inhibit the production of HIV-1 from 293T cells ( Figure 5 ). In contrast to wildtype CD4, however, this inhibition was not relieved by expression of Nef. Therefore, the internalization and degradation of cell-surface CD4 is key to the positive effect of Nef on virus production observed in these studies.
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Figure 4
Western analysis for cell-associated p24 Gag protein. Transfected 293T cells, remaining at the end of an experiment included in Figure 2 , were harvested after removal of the virus-containing supernatant and were then analyzed for levels of cell-associated p24 Gag (shown by the arrow) by western analysis using a rabbit polyclonal anti-HIV-1 p24 antiserum [45] and enhanced chemiluminescence. 
Figure 5
Specificity of the CD4/Nef effect on HIV-1 virion release. This experiment was performed as described in Figures 1 and 2 and examines the effect of substituting SIV mac239 Nef (Nef-S) in place of HIV-1 Nef, of substituting a CD4 mutant (mCD4) that is refractory to downregulation by HIV-1 Nef in place of wild-type human CD4, or of substituting an MLV amphotropic Env (Ampho) in place of HIV-1 Env, on the inhibition of HIV-1 virion release by CD4 and/or the rescue of this inhibition by Nef. Data represent the average of three experiments and were derived as described in Figure 3 . 
CD4 inhibition of HIV-1 virion release requires the HIV-1 Env protein
The model under analysis predicts that the retention of HIV-1 virions by CD4 is due to an interaction, at the cell surface, between CD4 and the HIV-1 Env protein present on budding virions. Therefore, if the Env protein used to pseudotype the pNL-Luc + E -R -provirus is not able to interact with CD4, no inhibition of virion release, and hence no rescue by HIV-1 Nef, should be observed. To test this hypothesis, we pseudotyped this HIV-1 provirus with an MLV amphotropic Env protein that is known to efficiently pseudotype HIV-1 virions [24] . As shown in Figure 5 , virions produced in the presence of amphotropic Env were comparable in infectivity to virions bearing the HIV-1 Env protein. CD4 co-expression could not exert any inhibitory effect on the release of these infectious, amphotropic Env + HIV-1 virions, and the additional expression of Nef therefore had little positive effect on virus production. No luciferase activity was detected when the supernatant media from 293T cells transfected with pNL-Luc + E -R -in the absence of an Env expression plasmid were analyzed (data not shown).
The Nef SH3 motif is not required for enhanced virion release from CD4 + cells
Although the domain organization of Nef remains incompletely defined, there has been considerable interest in a proline motif, located between Nef residues 69 and 78, that seems to function as an Src homology region 3 (SH3)-binding motif [17, 26, 37] . Interestingly, mutagenesis of this motif, and particularly of prolines at positions 72 and 75, blocks the enhancing effect of Nef on virion infectivity, the ability of Nef to downregulate class I MHC and the ability of Nef to interact with certain tyrosine kinases in vitro [17, 26] . In contrast, the integrity of this motif is not required for efficient downregulation of cell-surface CD4 [26, 38] .
To test the role of this SH3 motif in the observed enhancement by Nef of HIV-1 release from CD4 + cells, we compared the biological activity of wild-type Nef with two previously described Nef mutants mutated at either proline 72 (P72L) or at proline 75 (VP74/75LA) [38] . Both mutants are effectively expressed and retain the ability to downregulate cell-surface CD4. As shown in Figure 6 , both these mutants also retain the ability to rescue the inhibition of HIV-1 release induced by CD4 either in the presence or absence of Lck. Comparison of the data in Figure 6 with those in Figure 3b reveals that, although both these mutants can restore virion release to the level seen in the absence of either CD4 or Nef, they do not share the ability of wild-type Nef to enhance infectious virus production by an additional twofold. The significance of this result is discussed below.
Discussion
Of the biological activities that have been assigned to the HIV-1 Nef protein -downregulation of cell-surface CD4 and class I MHC, enhancement of virion infectivity, and possibly also increased activation of expressing cellsdownregulation of the CD4 receptor was the first to be reported [10, 39] and has been extensively confirmed [7] [8] [9] 11, 15, 19, 26, 38] . The purpose of this downregulation has remained unclear, however. The specific removal by viruses of their cognate receptor from the surface of infected cells is not, however, uncommon. One of the best studied examples is influenza virus. The viral enzyme neuraminidase (NA) specifically destroys the cell-surface sialic acid receptor for influenza virus [40, 41] . In the absence of NA, infection proceeds normally, but progeny influenza virions are unable to leave the infected cell and instead aggregate on the cell surface.
Whereas NA is critical for influenza virus replication both in culture and in vivo, Nef is largely dispensable for HIV-1 replication in culture [21, 29, 30] and, although important for efficient HIV-1 replication in vivo [29, 31] , it is nevertheless not essential [32] . Thus, the combined phenotype of all the activities assigned to Nef is relatively modest and 618 Current Biology, Vol 9 No 12
Figure 6
Effect of mutation of the Nef SH3-binding motif on the rescue of virion release from CD4 + cells. This experiment was performed as described in Figure 2 except that two previously described [38] HIV-1 Nef mutants lacking a functional SH3-binding motif were substituted in place of wild-type Nef. M72 bears a leucine in place of proline 72 (P72L) whereas M75 encodes leucine and alanine in place of valine and proline at residues 74 and 75 (VP74/75LA). These data represent the average of three experiments and were derived as described in Figure 3 . Current Biology the contribution of CD4 downregulation alone to efficient virus replication would be expected to be more modest still. Thus, if Nef-mediated downregulation of CD4 does indeed enhance the release of progeny HIV-1 virions from infected cells, then this enhancement must clearly be minor, at least in culture. Nevertheless, as pointed out by Coffin [42] , even a very small advantage on a per generation basis can exert a dramatic effect on the relative fitness of a virus that replicates as rapidly as HIV-1. Unfortunately, if the increase in the replication potential of HIV-1 that arises specifically from CD4 downregulation is indeed small, say less than 10% per replication cycle, then it would be difficult to measure with available techniques. The fact that mutations that are clearly specific for particular Nef activities are not yet available has also made it difficult to dissect the contribution of each distinct Nef activity to the composite Nef phenotype. Downregulation of CD4 by Nef would therefore seem unlikely to have a marked phenotype on a single replication cycle basis in cultured cells expressing physiological levels of cell-surface CD4. We circumvented this problem by asking whether this phenotype would become more obvious in cells with higher levels of cell-surface CD4. Specifically, we asked whether high levels of CD4 would block virion release and, more important, whether expression of Nef would reverse this block. This approach is valid if the likelihood that a progeny HIV-1 virion would encounter a cell-surface CD4 molecule during, or immediately after, budding is proportional to the level of expression of CD4 on the surface. If this is true, then increasing the level of CD4 expression should make evident a phenotype that, although real, is normally difficult to detect. We therefore carried out these experiments using FACS-sorted 293T cells that express high levels of CD4 or CD8, either in the presence or absence of Lck. These sorted cells were then transfected with the defective pNL-Luc + E -R -provirus [34] , together with an Env expression plasmid, and the effect of CD4 and Nef on the efficiency of virus release was determined.
As shown in Figure 3 , CD4, but not CD8, inhibited HIV-1 virion release by around fivefold and this inhibition was more than rescued by co-expression of HIV-1 Nef. Similar results were obtained whether total released p24 Gag protein (Figure 3a) or total released infectious virus (Figure 3b ) was determined. As predicted by the hypothesis that CD4 causes retention of progeny HIV-1 virions whereas Nef facilitates virion budding, CD4 induced an increase in cell-associated p24 Gag in these transfected 293T cells that was reversed by HIV-1 Nef (Figure 4 ). Further analysis revealed that SIV Nef could also block CD4-induced inhibition of HIV-1 virion release ( Figure 5) . A mutant CD4 lacking a functional dileucine motif that is required for Nef downregulation caused an inhibition in HIV-1 virion release that proved refractory to rescue by Nef ( Figure 5) . Substitution of the HIV-1 Env protein with an envelope protein derived from an amphotropic MLV, which does not recognize CD4, blocked the inhibition of HIV-1 release caused by CD4 overexpression; the further expression of Nef therefore gave only a modest positive effect ( Figure 5 ). Together, these data strongly support the hypothesis that cell-surface CD4 can block the release of progeny HIV-1 virions by interacting with HIV-1 Env protein assembled onto budding virus particles, and that the specific downregulation and degradation of cell-surface CD4 caused by Nef can effectively alleviate this retention. We therefore propose that the Nef-mediated downregulation of CD4 of HIV's host cells in vivo contributes to the effective spread of the virus in the infected host by facilitating progeny virion release.
When we started these experiments, we expected that the reported enhancing effect of Nef on the relative infectivity of progeny HIV-1 virions [21] [22] [23] [24] [25] would complicate the interpretation of our results. It has been reported that coexpression of Nef can enhance the infectivity of HIV-1 virions produced in 293T cells by 4-40-fold [24] . In contrast, we consistently failed to see any significant effect of Nef on specific virion infectivity (Figure 3b , and data not shown). Our experiments were performed using a CCR-5-tropic envelope, rather than the CXCR-4-tropic envelope used previously [24] , and we measured relative infectivity on CD4 + CCR-5 + 293T cells, whereas earlier work used CD4 + HeLa cells [24] . Although these experimental differences might largely explain this discrepancy, we note that a 10-fold infectivity advantage for Nef-expressing HIV-1 virions on a per generation basis should produce differences of several orders of magnitude in the level of virus replication, relative to Nef -HIV-1, when measured over many generations. In fact, such large differences were not observed when the level of replication of Nefversus Nef + HIV-1 was compared in either CD4 + T-cell lines or activated primary T cells [21, 30] or when wildtype SIV mac239 , which carries a biologically active nef gene, was compared with a Nef -form in primary rhesus monkey T cells or macrophages [29] . It is therefore possible that the large effect of Nef on virion infectivity seen upon infection of CD4 + HeLa cells is not representative of CD4 + cells in general. This question clearly merits examination in more detail.
Although we did not detect any significant effect of Nef on relative virion infectivity, we did note a small, around twofold, effect of Nef on the level of total or infectious progeny virion release even in the absence of CD4 or HIV-1 Env (Figures 3,5 ). This effect, although quite modest, did appear specific in that it was lost upon mutation of the HIV-1 Nef SH3-binding motif ( Figure 6 ) and was not detected when SIV Nef was used ( Figure 5 ). The level of cell-associated p24 present in Nef-expressing cells, even in the presence of CD4, was actually observed in some experiments to be below the level seen in cells expressing neither CD4 or Nef (Figure 4 , compare lanes 2 and 4). This might suggest that Nef can modestly facilitate HIV-1 virion release even in the absence of cell-surface CD4, a result that is intriguing in light of recent data suggesting that Nef could exert exactly such an effect [43] . Nevertheless, it is apparent from these data that the major positive effect of Nef on the efficiency of progeny HIV-1 virion release is likely to be from CD4-positive, and particularly from strongly CD4-positive, infected cells.
Conclusions
Using a transfection assay in HIV-1-permissive human 293T cells, we show that high-level expression of cellsurface CD4, but not of CD8, results in inhibition of the release of progeny HIV-1 virions. An equivalent degree of inhibition was observed regardless of whether total released virions or only released infectious virus was measured. Co-expression of either HIV-1 or SIV Nef in the virus-producing cells entirely reversed the inhibition caused by wild-type CD4, but did not affect the degree of inhibition caused by a CD4 mutant that is refractory to internalization in the presence of Nef. Together, these data demonstrate that cell-surface CD4 can inhibit the release of progeny virions from infected cells and suggest that the internalization and degradation of cell-surface CD4 induced by Nef is designed to prevent this effect and thus to increase virus spread in vivo.
Materials and methods
Construction of molecular clones
The LMN-1 expression plasmid is an MLV-based retroviral vector, derived from the previously described pBMN-Z [44] , that contains an internal cytomegalovirus immediate early (CMV-IE) promoter element. Wild-type human CD4 and CD8 cDNAs, as well as the previously described LS414/415AA CD4 mutant [15] , were amplified by polymerase chain reaction (PCR), inserted into pLMN-1 and expressed under the control of the CMV-IE promoter element. The human LCK gene was also PCR-amplified and expressed under the control of the MLV 5′ long terminal repeat promoter present in the same plasmid. The LMN-1 plasmid does not contain an SV40 origin of replication.
An expression plasmid, based on pCR3.1 (Invitrogen), that expresses the CCR-5-tropic HIV-1 strain ADA env gene has been described [35] . An equivalent plasmid expressing an MLV amphotropic env gene [24] was constructed by PCR amplification of this viral gene followed by insertion into pCR3.1. The pCR3.1 expression plasmids encoding the wild-type HIV-1 strain NL4-3 nef gene, the previously described HIV-1 nef mutants P72L and VP74/75LA [37] or the SIV mac239 nef gene [29] were constructed similarly.
Transfection assays
Human 293T cells were maintained as described [35] and were plated at 5 × 10 5 cells per 35-mm well in six-well plates. The next day, the cells were transfected with 2 µg of an expression plasmid encoding CD4 or CD8 plus or minus Lck, or with the blank LMN-1 plasmid, using lipofectamine. At ~70 h after transfection, the cells were harvested and stained with an anti-CD4 monoclonal antibody (Q4120, Sigma), an anti-CD8 monoclonal antibody (UCHT-4, Sigma) or were mock stained [15] . The cells were then sorted by FACS, using a FACScan machine (Becton-Dickinson), and the most intensely fluorescent ~15% of the CD4-and CD8-transfected 293T cells were harvested and replated at 3 × 10 5 cells per 35-mm dish. In parallel, control-transfected 293T cells were also passed through the FACScan, but not sorted, and also plated at 3 × 10 5 cells per 35-mm dish.
After overnight recovery, the cells were again transfected, using lipofectamine, with 500 ng pNL-Luc + E -R - [34] , 500 ng env expression plasmid, 500 ng nef expression plasmid and 500 ng parental pCR3.1 plasmid. Where appropriate, pCR3.1 DNA was substituted for the nef expression plasmid. In some cases, cells were harvested at ~44 h after this second transfection and then analyzed for cell-surface CD4 expression by FACS using the L120 monoclonal antibody [36] which does not block HIV-1 Env binding to CD4 (Becton-Dickinson). Alternatively, at ~63 h after this second transfection, supernatant media were harvested and an aliquot analyzed for p24 Gag levels using commercial ELISA (NEN Life Sciences). The remaining supernatant media were passed through an 0.2 µm filter and 1 ml used to infect a target cell culture. The transfected cells remaining in the plate were also harvested and analyzed by western blotting.
Virus infection assays
These were performed as described [35] . Briefly, 293T cells (35-mm cultures) were transfected with previously described [35] expression plasmids encoding human CD4 and CCR-5. Two days after transfection, the supernatant media were removed and replaced with 1 ml fresh medium and 1 ml virus-containing medium. The infected cells were lysed two days post-infection and then assayed for luciferase activity as previously described [35] .
Western blot analysis
The transfected cells remaining at the end of the above transfection procedure were harvested, lysed [15] and equal aliquots loaded onto a 12% polyacrylamide/SDS gel. The resolved proteins were transferred onto a nitrocellulose membrane (Amersham) and incubated with a 1:1000 dilution of a polyclonal rabbit anti-HIV-1 p24 Gag antiserum [45] in PBS containing 0.1% Tween 20 and 1% nonfat dry milk. After extensive washing of the membrane, bound rabbit antibodies were detected using a 1:1000 dilution of a horseradish peroxidase-conjugated goat anti-rabbit antiserum and enhanced chemiluminescence (Amersham).
